Avalo Therapeutics, Inc. (AVTX): Total Assets
$116.46M
As of 2025-12-31
$490.78M
As of 2026-06-30
+51.7%
3-year compound annual growth
+21.6%
5-year compound annual growth
+18.3%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $116.46M | -22.7% | 2026-03-23, Balance as of period end |
| 2024-12-31 | $150.73M | +618.0% | 2026-03-23, Balance as of period end |
| 2023-12-31 | $20.99M | -37.1% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $33.37M | -58.4% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $80.21M | +83.3% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $43.76M | +21.2% | 2022-03-02, Balance as of period end |
| 2019-12-31 | $36.11M | -48.6% | 2021-03-08, Balance as of period end |
| 2018-12-31 | $70.25M | +64.1% | 2020-03-11, Balance as of period end |
| 2017-12-31 | $42.81M | +642.0% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $5.77M | -73.4% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $21.66M | +75.8% | 2017-03-14, Balance as of period end |
| 2014-12-31 | $12.32M | n/a | 2016-03-23, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $56.08M | -44.6% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $24.52M | -18.9% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $74.31M | -34.4% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $7.61M | +2.6% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $279.93M | +100.9% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $20.45M | +19.9% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $2.82M | -17.4% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $51.77M | -32.7% |
Compare AVTX, CNTB, HCWB, INO side by side · Screen every company in Pharmaceutical Preparations ↗